Guangdong Winsun Bio-Pharmaceutical Co Ltd was one of the 32 listed firms that made their market debuts on the National Equities Exchange and Quotations (NEEQ) Select Tier on July 28, being the only one of its kind in Guangzhou.
The NEEQ Select Tier, also called the "new third board," is China's newly launched equity market for small- and medium-sized enterprises.
Registered to be set up in 2002, Guangdong Winsun Bio-Pharmaceutical Co Ltd is mainly involved in businesses integrating the research and development, manufacturing, marketing, as well as technical services of animal biological products.
The funds raised through the company's public share offering will be used in R&D projects of animal biological products to increase the company's comprehensive competitiveness.
We provide up-to-date information and rich resources about China's EDZs.
If you have questions, please feel free to let us know.